These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 12241875)

  • 1. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.
    Klein CA; Blankenstein TJ; Schmidt-Kittler O; Petronio M; Polzer B; Stoecklein NH; Riethmüller G
    Lancet; 2002 Aug; 360(9334):683-9. PubMed ID: 12241875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.
    Austrup F; Uciechowski P; Eder C; Böckmann B; Suchy B; Driesel G; Jäckel S; Kusiak I; Grill HJ; Giesing M
    Br J Cancer; 2000 Dec; 83(12):1664-73. PubMed ID: 11104564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells.
    Pantel K; Otte M
    Semin Cancer Biol; 2001 Oct; 11(5):327-37. PubMed ID: 11562175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma].
    von Knebel Doeberitz M; Koch M; Weitz J; Herfarth C
    Zentralbl Chir; 2000; 125 Suppl 1():15-9. PubMed ID: 10929641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
    Rosenberg R; Nekarda H; Thorban S; Siewert JR
    Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN.
    Wollenberg B; Walz A; Kolbow K; Pauli C; Chaubal S; Andratschke M
    Onkologie; 2004 Aug; 27(4):358-62. PubMed ID: 15347890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
    Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.
    Tachtsidis A; McInnes LM; Jacobsen N; Thompson EW; Saunders CM
    Clin Exp Metastasis; 2016 Aug; 33(6):521-50. PubMed ID: 27189371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
    Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From single disseminated tumor cells to metastasis insights from molecular genetic analyses of single cells].
    Klein CA
    Verh Dtsch Ges Pathol; 2003; 87():158-64. PubMed ID: 16888908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
    Giesing M; Suchy B; Driesel G; Molitor D
    BJU Int; 2010 Apr; 105(7):1000-10. PubMed ID: 19818074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and clinical significance of occult tumour cells in colorectal cancer.
    Tsavellas G; Patel H; Allen-Mersh TG
    Br J Surg; 2001 Oct; 88(10):1307-20. PubMed ID: 11578283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer.
    Dang RK; Anthony RS; Craig JI; Leonard RC; Parker AC
    Mol Pathol; 2002 Jun; 55(3):177-81. PubMed ID: 12032228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.